230 related items for PubMed ID: 11773988
1. Comparison of quality of life and cough on eprosartan and enalapril in people with moderate hypertension.
Breeze E, Rake EC, Donoghue MD, Fletcher AE.
J Hum Hypertens; 2001 Dec; 15(12):857-62. PubMed ID: 11773988
[Abstract] [Full Text] [Related]
2. Quality of life and cough on antihypertensive treatment: a randomised trial of eprosartan, enalapril and placebo.
Rake EC, Breeze E, Fletcher AE.
J Hum Hypertens; 2001 Dec; 15(12):863-7. PubMed ID: 11773989
[Abstract] [Full Text] [Related]
3. Double-blind comparison of eprosartan and enalapril on cough and blood pressure in unselected hypertensive patients. Eprosartan Study Group.
Elliott WJ.
J Hum Hypertens; 1999 Jun; 13(6):413-7. PubMed ID: 10408592
[Abstract] [Full Text] [Related]
4. Eprosartan mesylate effectively reduces systolic and diastolic blood pressure in a Canadian primary care setting.
Conter HS, McKay DW, Reiz RJ.
Can J Cardiol; 2004 Oct; 20 Suppl C():6C-10C. PubMed ID: 16807617
[Abstract] [Full Text] [Related]
5. Once-daily eprosartan mesylate in the treatment of elderly patients with isolated systolic hypertension: data from a 13-week double-blind, placebo-controlled, parallel, multicenter study.
Punzi HA, Punzi CF.
J Hum Hypertens; 2004 Sep; 18(9):655-61. PubMed ID: 15042114
[Abstract] [Full Text] [Related]
6. Eprosartan provides safe and effective long-term maintenance of blood pressure control in patients with mild to moderate essential hypertension.
Levine B.
Curr Med Res Opin; 2001 Sep; 17(1):8-17. PubMed ID: 11464450
[Abstract] [Full Text] [Related]
7. The angiotensin receptor blocker eprosartan mesylate reduces pulse pressure in isolated systolic hypertension.
Teitelbaum I, Chilvers M, Reiz RJ.
Can J Cardiol; 2004 Oct; 20 Suppl C():11C-16C. PubMed ID: 16807618
[Abstract] [Full Text] [Related]
8. The effect of treatment with eprosartan on pulse pressure: factors predicting response.
de la Sierra A, Muñoz A, Arcos E, López JS, Relats J, ETAPA-2 study investigators.
Can J Cardiol; 2004 Oct; 20 Suppl C():17C-22C. PubMed ID: 16807619
[Abstract] [Full Text] [Related]
9. Efficacy of eprosartan in combination with HCTZ in patients with essential hypertension.
Sachse A, Verboom CN, Jäger B.
J Hum Hypertens; 2002 Mar; 16(3):169-76. PubMed ID: 11896506
[Abstract] [Full Text] [Related]
10. Efficacy and safety of eprosartan in severe hypertension. Eprosartan Multinational Study Group.
Sega R.
Blood Press; 1999 Mar; 8(2):114-21. PubMed ID: 10451039
[Abstract] [Full Text] [Related]
11. Effects of angiotensin converting enzyme inhibitor on renal function in patients of membranoproliferative glomerulonephritis with mild to moderate renal insufficiency.
Giri S, Mahajan SK, Sen R, Sharma A.
J Assoc Physicians India; 2002 Oct; 50():1245-9. PubMed ID: 12568207
[Abstract] [Full Text] [Related]
12. An open comparative clinical trial to assess the efficacy and safety of losartan versus enalapril in mild to moderate hypertension.
Chowta KN, Chowta MN, Bhat P, Adhikari PM.
J Assoc Physicians India; 2002 Oct; 50():1236-9. PubMed ID: 12568205
[Abstract] [Full Text] [Related]
13. Efficacy and safety of delapril plus manidipine compared with enalapril plus hydrochlorothiazide in mild to moderate essential hypertension: results of a randomized trial.
Mugellini A, Dobovisek J, Planinc D, Cremonesi G, Fogari R.
Clin Ther; 2004 Sep; 26(9):1419-26. PubMed ID: 15531004
[Abstract] [Full Text] [Related]
14. Dechallenge and rechallenge method showed different incidences of cough among four ACE-Is.
Tumanan-Mendoza BA, Dans AL, Villacin LL, Mendoza VL, Rellama-Black S, Bartolome M, Ragual J, Flor B, Valdez J.
J Clin Epidemiol; 2007 Jun; 60(6):547-53. PubMed ID: 17493508
[Abstract] [Full Text] [Related]
15. Effect of eprosartan and enalapril in the treatment of elderly hypertensive patients: subgroup analysis of a 26-week, double-blind, multicentre study. Eprosartan Multinational Study Group.
Argenziano L, Trimarco B.
Curr Med Res Opin; 1999 Jun; 15(1):9-14. PubMed ID: 10216806
[Abstract] [Full Text] [Related]
16. Effect of eprosartan and enalapril in the treatment of black hypertensive patients: subgroup analysis of a 26-week, double-blind, multicentre study. Eprosartan Multinational Study Group.
Levine B.
Curr Med Res Opin; 1999 Jun; 15(1):25-32. PubMed ID: 10216808
[Abstract] [Full Text] [Related]
17. Effect of eprosartan on cytoplasmic free calcium mobilization, platelet activation, and microparticle formation in hypertension.
Labiós M, Martínez M, Gabriel F, Guiral V, Munoz A, Aznar J.
Am J Hypertens; 2004 Sep; 17(9):757-63. PubMed ID: 15363816
[Abstract] [Full Text] [Related]
18. Effects of hypertension therapy based on eprosartan on systolic arterial blood pressure and cognitive function: primary results of the Observational Study on Cognitive function And Systolic Blood Pressure Reduction open-label study.
Hanon O, Berrou JP, Negre-Pages L, Goch JH, Nádházi Z, Petrella R, Sedefdjian A, Sévenier F, Shlyakhto EV, Pathak A.
J Hypertens; 2008 Aug; 26(8):1642-50. PubMed ID: 18622244
[Abstract] [Full Text] [Related]
19. Eprosartan versus enalapril in elderly patients with hypertension: a double-blind, randomized trial.
Ruilope L, Jäger B, Prichard B.
Blood Press; 2001 Aug; 10(4):223-9. PubMed ID: 11800061
[Abstract] [Full Text] [Related]
20. Effects of eprosartan versus enalapril in hypertensive patients on the renin-angiotensin-aldosterone system and safety parameters: results from a 26-week, double-blind, multicentre study. Eprosartan Multinational Study Group.
Gavras I, Gavras H.
Curr Med Res Opin; 1999 Aug; 15(1):15-24. PubMed ID: 10216807
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
